Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 10/20 | 0.76 |
| ▸ | MMP13 | P45452 | 9/20 | 0.74 |
| ▸ | MMP1 | P03956 | 8/20 | 0.74 |
| ▸ | MMP8 | P22894 | 8/20 | 0.74 |
| ▸ | MMP2 | P08253 | 4/20 | 0.74 |
| ▸ | MMP14 | P50281 | 4/20 | 0.74 |
| ▸ | MMP9 | P14780 | 3/20 | 0.74 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.74 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.67 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.67 |
| ▸ | MMP7 | P09237 | 5/20 | 0.57 |
| ▸ | MMP12 | P39900 | 5/20 | 0.57 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.55 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.51 |
| ▸ | BMP1 | P13497 | 1/20 | 0.50 |
| ▸ | MMP16 | P51512 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7347286 | 0.89 | MMP3 (0.76) | MMP3MMP13MMP1MMP8MMP2 | |
| SCHEMBL7340897 | 0.89 | MMP3 (0.76) | MMP3MMP13MMP1MMP8MMP2 | |
| SCHEMBL7349859 | 0.87 | MMP3 (0.74) | MMP3MMP13MMP1MMP8MMP2 | |
| SCHEMBL7343386 | 0.87 | MMP3 (0.74) | MMP3MMP13MMP1MMP8MMP2 | |
| SCHEMBL7343903 | 0.87 | MMP3 (0.74) | MMP3MMP13MMP1MMP8MMP2 | |
| SCHEMBL7351771 | 0.87 | MMP3 (0.85) | MMP3MMP13MMP1MMP8MMP2 | |
| SCHEMBL7343818 | 0.86 | MMP3 (1.00) | MMP3MMP13MMP1MMP8MMP2 | |
| SCHEMBL598146 | 0.85 | MMP3 (0.79) | MMP3MMP13MMP1MMP8MMP2 | |
| SCHEMBL26770282 | 0.85 | MMP3 (0.70) | MMP3MMP13MMP1MMP8MMP2 | |
| SCHEMBL7342296 | 0.84 | MMP3 (0.69) | MMP3MMP13MMP1MMP8MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357139-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | Artizan Biosciences, Inc. | 2023-11-09 | — | — | US | disclosed |
| US-20230357139-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | Artizan Biosciences, Inc. | 2023-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357139-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | FABP2, APC, SI | MMP3 454/4885MMP13 312/4885MMP1 643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.